Pediatric Blood & Cancer, 1545-5017

Journal

More filtering options
  1. 2008
  2. Experiences and needs of children with cancer and their families in a longitudinal perspective

    Maria Björk, Thomas Wiebe & Inger Hallström, 2008, In: Pediatric Blood & Cancer. 49, 4: Suppl, p. 557

    Research output: Contribution to journalPublished meeting abstract

  3. 2007
  4. Mortality experiences among 15+ year survivors of childhood and adolescence cancers.

    Torgil Möller & Stanislaw Garwicz, 2007, In: Pediatric Blood & Cancer. 48, 3, p. 363-363

    Research output: Contribution to journalLetter

  5. Successful treatment of a child with t(15;19)-positive tumor.

    Fredrik Mertens, Thomas Wiebe, Catharina Adlercreutz, Nils Mandahl & Christopher A French, 2007, In: Pediatric Blood & Cancer. 49, p. 1015-1017

    Research output: Contribution to journalArticle

  6. 2006
  7. Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL)

    S. von Mackensen, Cecilia Nilsson, M. Jankovic, N. Mirra, E. D'Angelo, A. Borkhardt & Rolf Ljung, 2006, In: Pediatric Blood & Cancer. 47, Suppl.5, p. 688-691

    Research output: Contribution to journalArticle

  8. Studies of chronic ITP in children and adolescents.

    Cecilia Nilsson, Ulf Tedgård & Rolf Ljung, 2006, In: Pediatric Blood & Cancer. 47, S5, p. 660-661

    Research output: Contribution to journalArticle

  9. 2005
  10. Children with cancer and their families – a longitudinal approach

    Maria Björk, Thomas Wiebe & Inger Hallström, 2005, In: Pediatric Blood & Cancer. 45, p. 562-563 2 p.

    Research output: Contribution to journalPublished meeting abstract

  11. Development of an international pediatric oncology research network

    Roberta Woodgate, Juanne Clarke, Faith Gibson, Inger Hallström, Nancy Kline, Leanne Monterosso, Louise von Essen & Lena Wettergren, 2005, In: Pediatric Blood & Cancer. 45, 4, p. 400

    Research output: Contribution to journalPublished meeting abstract

  12. Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.

    Albert Békássy, Anna Locasciulli, Judith C W Marsh, Gerard Socié, Monika Fuehrer & Jakob Passweg, 2005, In: Pediatric Blood & Cancer. 45, 3, p. 359-360

    Research output: Contribution to journalLetter

  13. Needs of children with cancer during their initial hospitalization

    Maria Björk, Berit Nordström & Inger Hallström, 2005, In: Pediatric Blood & Cancer. 45, 4, p. 564

    Research output: Contribution to journalArticle

  14. Needs of young children with cancer during their initial hospitalization.

    Maria Björk, Berit Nordström & Inger Hallström, 2005, In: Pediatric Blood & Cancer. 45, 4, p. 564

    Research output: Contribution to journalPublished meeting abstract

  15. 2004
  16. Childhood cancer: the family experience

    M B Björk & Inger Hallström, 2004, In: Pediatric Blood & Cancer. 43, 4, p. 336

    Research output: Contribution to journalPublished meeting abstract

  17. Parents’ and children’s involvement in decision-making during hospitalisation

    Inger Hallström, 2004, In: Pediatric Blood & Cancer. 43, p. 307

    Research output: Contribution to journalPublished meeting abstract

  18. 2002
  19. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi-institutional collaborative study

    BM Frost, S Eksborg, O Bjork, J Abrahamsson, M Behrendtz, Anders Castor, E Forestier & G Lonnerholm, 2002, In: Medical and Pediatric Oncology. 38, 5, p. 329-337

    Research output: Contribution to journalArticle

  20. 2000
  21. 1999
  22. Cytogenetic aberrations in Ewing sarcoma: are secondary changes associated with clinical outcome?

    Carl-Magnus Kullendorff, Fredrik Mertens, M Donner, Thomas Wiebe, Måns Åkerman & Nils Mandahl, 1999, In: Medical and Pediatric Oncology. 32, 2, p. 79-83

    Research output: Contribution to journalArticle

  23. Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumors

    Marianne Schmiegelow, Sören Lassen, Lars Weber, Hans Skovgaard-Poulsen, Henrik Hertz & Joern Müller, 1999, In: Medical and Pediatric Oncology. 33, 6, p. 564-571

    Research output: Contribution to journalArticle

  24. 1997
  25. Letter to the editor: Uncertain role of high dose chemotherapy with autologous stem cell support in pediatric pleuro-pulmonary blastoma (PPB)

    Albert Békássy, Stanislaw Garwicz, Thomas Wiebe & Inga Hägerstrand, 1997, In: Medical and Pediatric Oncology. 28, 1, p. 75-76

    Research output: Contribution to journalLetter

  26. 1992
  27. Hepatocellular carcinoma associated with arteriohepatic dysplasia in a 4-year-old girl

    Albert Békássy, Stanislaw Garwicz, Thomas Wiebe, Inga Hägerstrand & Ove A Jensen, 1992, In: Medical and Pediatric Oncology. 20, 1, p. 78-83

    Research output: Contribution to journalArticle

  28. 1990
  29. Letter to the editor: "Role of chemotherapy in pediatric pulmonary blastoma" by Ozkaynak et al., 1990

    Albert Békássy, Inga Hägerstrand, Henrik Henrikson, Stanislaw Garwicz & Thomas Wiebe, 1990, In: Medical and Pediatric Oncology. 18, 5, p. 359-359

    Research output: Contribution to journalLetter

  30. Pharmacokinetics of cytosine arabinoside in cerebrospinal fluid and of its metabolite in leukemic cells

    Albert Békássy, Jan Liliemark, Stanislaw Garwicz, Thomas Wiebe, Hans Gulliksson & Curt Peterson, 1990, In: Medical and Pediatric Oncology. 18, 2, p. 136-142

    Research output: Contribution to journalArticle

  31. 1989
  32. Radio-iodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations

    Kjeld Schmiegelow, Martti A Simes, Lone Agertoft, Gunilla Berglund, Ingebjörn Storm-Mathisen, Michael Andreassen, Toivo T Salmi, Randi Nygard, Thomas Wiebe, Anders Kreuger & Salah Hayder, 1989, In: Medical and Pediatric Oncology. 17, 2, p. 126-130

    Research output: Contribution to journalArticle

Previous 1 2 3 Next